Hims & Hers Health, Inc.

BMV:HIMS * Stock Report

Market Cap: Mex$97.2b

Hims & Hers Health Management

Management criteria checks 2/4

Hims & Hers Health's CEO is Andrew Dudum, appointed in Jan 2017, has a tenure of 7.83 years. total yearly compensation is $14.40M, comprised of 4.2% salary and 95.8% bonuses, including company stock and options. directly owns 8.61% of the company’s shares, worth MX$8.37B. The average tenure of the management team and the board of directors is 2.7 years and 2.9 years respectively.

Key information

Andrew Dudum

Chief executive officer

US$14.4m

Total compensation

CEO salary percentage4.2%
CEO tenure7.8yrs
CEO ownership8.6%
Management average tenure2.7yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Andrew Dudum's remuneration changed compared to Hims & Hers Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$101m

Jun 30 2024n/an/a

US$18m

Mar 31 2024n/an/a

-US$2m

Dec 31 2023US$14mUS$612k

-US$24m

Sep 30 2023n/an/a

-US$36m

Jun 30 2023n/an/a

-US$47m

Mar 31 2023n/an/a

-US$59m

Dec 31 2022US$11mUS$600k

-US$66m

Sep 30 2022n/an/a

-US$86m

Jun 30 2022n/an/a

-US$83m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$15mUS$574k

-US$108m

Sep 30 2021n/an/a

-US$82m

Jun 30 2021n/an/a

-US$72m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$27mUS$527k

-US$18m

Sep 30 2020n/an/a

-US$25m

Jun 30 2020n/an/a

-US$38m

Mar 31 2020n/an/a

-US$58m

Dec 31 2019US$254kUS$254k

-US$72m

Compensation vs Market: Andrew's total compensation ($USD14.40M) is above average for companies of similar size in the MX market ($USD1.24M).

Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.

CEO

Andrew Dudum (35 yo)

7.8yrs

Tenure

US$14,401,411

Compensation

Mr. Andrew Dudum serves as Chairman of the Board and serves as Chief Executive Officer at Hims & Hers Health, Inc. since January 20, 2021. He Co-Founded Hims & Hers Health, Inc. in 2017. He is Co-founded H...

Leadership Team

NamePositionTenureCompensationOwnership
Andrew Dudum
Co-Founder7.8yrsUS$14.40m8.61%
MX$ 8.4b
Yemi Okupe
Chief Financial Officer2.8yrsUS$7.43m0.051%
MX$ 49.9m
Melissa Baird
Chief Operating Officer3.8yrsUS$6.77m0.29%
MX$ 280.3m
Soleil Boughton
Chief Legal Officer & Corporate Secretary3.8yrsUS$5.21m0.077%
MX$ 74.5m
Patrick Carroll
Chief Medical Officer1.9yrsUS$198.26k0.088%
MX$ 85.5m
Mike Chi
Chief Commercial Officerless than a yearUS$6.71m0.084%
MX$ 81.8m
Irene Becklund
Senior VP5.4yrsUS$961.12k0.0023%
MX$ 2.3m
Khobi Brooklyn
Chief Communications Officer1.1yrsno datano data
Amee Parekh
Senior Vice President of Human Resources2.7yrsno datano data
Peter Stahl
Senior VP & Member of Medical Advisory Boardno datano datano data
Scott Knoer
Chief Pharmacy & Innovation Officer1.9yrsno datano data
Daniel Lieberman
Senior Vice President of Mental Health1.7yrsno datano data

2.7yrs

Average Tenure

44yo

Average Age

Experienced Management: HIMS *'s management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andrew Dudum
Co-Founder3.8yrsUS$14.40m8.61%
MX$ 8.4b
Patrick Carroll
Chief Medical Officer2.8yrsUS$198.26k0.088%
MX$ 85.5m
Peter Stahl
Senior VP & Member of Medical Advisory Board2.8yrsno datano data
Delos Cosgrove
Independent Director4.2yrsUS$194.26k0.025%
MX$ 24.2m
David Wells
Lead Independent Director4.2yrsUS$227.41k0.071%
MX$ 69.4m
Andrea Perez Garcia
Independent Director3.7yrsUS$205.51k0.033%
MX$ 32.4m
Amy Voedisch
Member of Medical Advisory Board2.9yrsno datano data
Lawrence Jenkins
Member of Medical Advisory Boardno datano datano data
Bertha Chen
Member of Medical Advisory Board2.9yrsno datano data
Denise Asafu-Adjei
Member of Medical Advisory Board2.9yrsno datano data
Stanton Honig
Member of Medical Advisory Board2.9yrsno datano data
Stanley Althof
Member of Medical Advisory Board2.9yrsno datano data

2.9yrs

Average Tenure

53yo

Average Age

Experienced Board: HIMS *'s board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.